logo

For the Inventor, By the Inventor

Taipei, Taiwan

Wen-Tai Li

This inventor holds 7 USPTO granted patents. Top assignee: National Health Research Institutes. Active years: 2004-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wen-Tai Li. Retrieved from https://idiyas.com/inventor/wen-tai-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 28.6

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Hsinchu, TW (2004 - 2009)
  • Taipei, TW (2005 - 2010)

Company Filing History:

goldMedal7 out of 189 
 
National Health Research Institutes
 patents

Years Active: 2004-2010

Loading Chart...
7 patents (USPTO):Explore Patents
1. 7662834 - Methods of 1H-indol-3-yl-2-oxoacetamide compounds (2010-02-16),
2. 7569596 - Imidazolamino compounds (2009-08-04),
3. 7462723 - Imidazolamino compounds (2008-12-09),
4. 7396838 - Use of 1H-indol-3-yl-2-oxoacetamide compounds (2008-07-08),
5. 7109227 - Imidazolamino compounds (2006-09-19),
6. 6903104 - Indol-3-YL-2-oxoacetamide compounds and methods of use thereof (2005-06-07),
7. 6706739 - Imidazolidinone compounds (2004-03-16),

Title: The Innovative Contributions of Wen-Tai Li

Introduction

Wen-Tai Li is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. With a total of 7 patents to his name, Li's work is recognized for its potential impact on medical science.

Latest Patents

Among his latest patents, one notable invention is related to "Methods of 1H-indol-3-yl-2-oxoacetamide compounds." This invention focuses on treating cancer or an angiogenesis-related disease using a specific compound formula. Another significant patent involves "Imidazolamino compounds," which are novel compounds that also have applications in cancer treatment. These patents highlight Li's commitment to advancing therapeutic options for patients.

Career Highlights

Wen-Tai Li is affiliated with the National Health Research Institutes, where he conducts his research. His work is characterized by a strong emphasis on developing effective treatments for serious health conditions. Li's innovative approach has garnered attention in the scientific community, contributing to advancements in cancer therapies.

Collaborations

Li has collaborated with notable colleagues, including Chiung-Tong Chen and Der-Ren Hwang. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality and impact of their research.

Conclusion

Wen-Tai Li's contributions to the field of cancer treatment through his innovative patents demonstrate his dedication to improving healthcare outcomes. His work continues to inspire future research and development in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…